2017-03-15,GTx Provides Corporate Update And Reports Fourth Quarter And Year-End 2016 Financial Results
2017-03-07,GTx, Inc. To Report Fourth Quarter And Full Year 2016 Financial Results On March 15, 2017
2016-12-08,GTx Reports Results From Ongoing Enobosarm Phase 2 Clinical Trial In ER+/AR+ Breast Cancer
2016-12-05,GTx, Inc. Announces 1-for-10 Reverse Stock Split
2016-11-28,Enobosarm Meets Pre-Specified Primary Efficacy Endpoint In Ongoing Phase 2 Clinical Trial In ER+/AR+ Breast Cancer
2016-11-23,GTx Announces Webcast Of Corporate Presentation At The 28th Annual Piper Jaffray Healthcare Conference
2016-11-16,GTx Achieves Second Stage 1 Milestone In Phase 2 Clinical Trial Of Enobosarm In ER+/AR+ Breast Cancer
2016-11-11,GTx Announces Webcast Of Corporate Presentation At The Stifel 2016 Healthcare Conference
2016-11-03,GTx Provides Corporate Update And Reports Third Quarter 2016 Financial Results
2016-10-12,GTx Announces $14.0 Million Registered Direct Common Stock Offering
2016-09-08,GTx Achieves Stage 1 Milestone In Phase 2 Clinical Trial Of Enobosarm In ER+/AR+ Breast Cancer
2016-09-02,GTx Announces Webcast Of Corporate Presentation At Baird's 2016 Healthcare Conference
2016-09-01,GTx Appoints Dr. Garry Neil To Board Of Directors
2016-08-09,GTx Provides Corporate Update And Reports Second Quarter 2016 Financial Results
2016-07-05,XBiotech Cancer Drug Survival Claim Falls Apart Under Scrutiny
2016-06-02,GTx Announces Webcast Of Corporate Presentation At Jefferies 2016 Global Healthcare Conference
2016-05-16,GTx Announces Webcast Of Corporate Presentation At The UBS Global Healthcare Conference 2016
2016-05-10,GTx Provides Corporate Update And Reports First Quarter 2016 Financial Results
2016-05-09,GTx Announces Presentation Of Preclinical Data Demonstrating The Ability Of SARDs To Degrade And Inhibit The Androgen Receptor At The American Urological Association Annual Meeting
2016-04-27,GTx, Inc. To Report First Quarter 2016 Financial Results On May 10, 2016
2016-03-03,GTx Provides Corporate Update And Reports Fourth Quarter And Year-End 2015 Financial Results
2016-02-24,GTx Announces Presentation Of Preclinical Data Demonstrating The Effect Of GTx SARMs On Pelvic Floor Muscle Loss At The Society Of Urodynamics, Female Pelvic Medicine And Urogenital Reconstruction (SUFU) Meeting
2016-02-18,GTx, Inc. To Host Fourth Quarter And Full Year 2015 Financial Results Conference Call And Webcast
2016-01-13,GTx Announces Initiation Of Phase 2 Clinical Trial Of Enobosarm In Stress Urinary Incontinence
2015-10-29,GTx Provides Corporate Update And Reports Third Quarter 2015 Financial Results
2015-10-15,GTx, Inc. To Host Third Quarter 2015 Financial Results Conference Call And Webcast
2015-10-13,GTx Receives FDA Clearance To Initiate Clinical Trial In Stress Urinary Incontinence
2015-10-06,GTx Announces Enrollment Of First Patient In Phase 2 Clinical Trial Of Enobosarm In Triple Negative Breast Cancer
2015-09-29,GTx Announces Enrollment Of First Patient In Phase 2 Clinical Trial Of Enobosarm In ER+/AR+ Breast Cancer
2015-08-06,GTx Provides Corporate Update And Reports Second Quarter 2015 Financial Results
2015-07-23,GTx, Inc. To Host Second Quarter 2015 Financial Results Conference Call And Webcast
2015-07-08,GTx Appoints Diane Young, M.D. As Vice President, Chief Medical Officer
2015-06-02,GTx Regains Compliance With NASDAQ Bid Price Requirement
2015-05-26,GTx Announces Webcast Of Corporate Presentation At Jefferies 2015 Global Healthcare Conference
2015-05-12,GTx Announces Webcast Of Corporate Presentation At The UBS Global Healthcare Conference 2015
2015-05-08,GTx Provides Corporate Update And Reports First Quarter 2015 Financial Results
2015-04-30,3 Stocks Under $10 to Trade for Big Breakouts
2015-04-23,GTx And The University Of Tennessee Research Foundation Enter Into Exclusive License Agreement To Develop UTRF's SARD Drug Technology
2015-04-02,GTx Provides Corporate Update Regarding NASDAQ Stock Listing
2015-03-04,GTx Provides Corporate Update And Reports Fourth Quarter And Year-End 2014 Financial Results
2015-02-19,GTx, Inc. To Host Fourth Quarter And Full Year 2014 Financial Results Conference Call And Webcast
2015-02-17,GTx Appoints Robert J. Wills, Ph.D. To Board Of Directors
2014-12-08,GTx To Present Results On Enobosarm 9mg In Women With Metastatic Breast Cancer At 2014 San Antonio Breast Cancer Symposium
2014-11-17,GTx Announces Closing Of $43.4 Private Placement
2014-11-12,GTx Announces Webcast Of Corporate Presentation At The Stifel 2014 Healthcare Conference
2014-11-10,GTx Provides Corporate Update And Reports Third Quarter 2014 Financial Results
2014-11-10,GTx Announces $43.4 Million Private Placement
2014-11-03,GTx, Inc. To Host Third Quarter 2014 Financial Results Conference Call And Webcast
2014-08-07,GTx Announces Webcast Of Corporate Presentation At The 2014 Wedbush Pacgrow Life Sciences Management Access Conference
2014-08-05,GTx Provides Corporate Update And Reports Second Quarter 2014 Financial Results
2014-07-22,GTx, Inc. To Report Second Quarter 2014 Financial Results On August 5, 2014
2014-07-02,4 Biotech Stocks Under $10 to Watch for Breakout Trades
2014-06-02,GTx Reports Positive Clinical Data From Open Label Phase 2 Study Of Enobosarm In Patients With Androgen And Estrogen Receptor Positive Metastatic Breast Cancer
2014-05-22,GTx Announces Webcast Of Corporate Presentation At Jefferies 2014 Global Healthcare Conference
2014-05-19,GTx To Present Clinical Data On Enobosarm In Breast Cancer And NSCLC At ASCO 2014 Annual Meeting
2014-05-08,GTx Provides Corporate Update And Reports First Quarter 2014 Financial Results
2014-04-24,GTx, Inc. To Report First Quarter 2014 Financial Results On May 8, 2014
2014-04-04,GTx Announces Departure Of CEO
2014-03-06,GTx, Inc. Announces Closing Of Private Placement
2014-03-05,GTx Announces Webcast Of Corporate Presentation At 26TH Annual ROTH Conference
2014-03-04,GTx Provides Corporate Update And Reports 2013 Financial Results
2014-03-04,GTx, Inc. Announces Pricing Of Private Placement
2014-02-26,GTx Announces Webcast Of Corporate Presentation At Cowen And Company 34th Annual Health Care Conference
2014-02-18,GTx, Inc. To Host Fourth Quarter And Full Year 2013 Financial Results Conference Call And Webcast
2014-02-04,First Week of March 22nd Options Trading For GTXI
2014-02-04,GTx Announces Webcast Of Corporate Presentation At Bio CEO &amp; Investor Conference
2014-01-29,Preliminary Findings From The Phase 2 Clinical Trial Of GTx-758 In Men With Castration Resistant Prostate Cancer To Be Presented At ASCO Genitourinary Cancer Symposium
2013-12-19,5 Stocks Under $10 Set to Soar
2013-12-12,GTx Presents On Enobosarm As Targeted Therapy For The Treatment Of Androgen Receptor-Positive Breast Cancer At The San Antonio Breast Cancer Symposium
2013-11-12,GTx Provides Corporate Update And Reports Third Quarter 2013 Financial Results
2013-10-29,GTx, Inc. To Host Third Quarter 2013 Financial Results Conference Call And Webcast
2013-10-24,GTx Presents Results From Enobosarm POWER Trials For The Prevention And Treatment Of Muscle Wasting In Patients With Non-Small Cell Lung Cancer At 15th World Conference On Lung Cancer
2013-09-24,GTx Announces Late Breaker Presentation On Results From The Two Phase 3 POWER Trials Of Enobosarm, A Selective Androgen Receptor Modulator (SARM), For The Prevention And Treatment Of Muscle Wasting In NSCLC Patients During 2013 European Cancer Congress
2013-09-16,5 Stocks Ready for Breakouts
2013-09-11,6 Under-$10 Stocks Moving Higher
2013-09-06,GTx Announces Webcast Of Corporate Presentation At Stifel Nicolaus 2013 Healthcare Conference
2013-08-29,GTx, Inc. Sued By Investor
2013-08-27,Short Interest In GTx Inc Increases 32%
2013-08-23,Top Insider Trades: GLP ACW GTXI AHH
2013-08-23,The 5 Dumbest Things on Wall Street This Week: Aug. 23
2013-08-23,5 Dumbest Things on Wall Street
2013-08-19,Shareholder Rights Law Firm Johnson &amp; Weaver, LLP Announces Investigation Of GTx Inc.
2013-08-19,GTXI SHAREHOLDER ALERT: The Law Firm Of Wohl &amp; Fruchter LLP Announces Investigation Of GTX Inc.
2013-08-19,GTx: Survival Spin Job Follows Enobosarm Study Flop
2013-08-19,GTx Reports Results For Enobosarm POWER Trials For The Prevention And Treatment Of Muscle Wasting In Patients With Non-Small Cell Lung Cancer
2013-08-12,Short Interest Moves 47.3% Higher For GTXI
2013-08-04,MannKind, Vical, GTx: Investors Predict Pivotal Clinical Trial Results
2013-08-02,GTx Inc Is Now Oversold (GTXI)
2013-07-19,GTx Provides Corporate Update And Second Quarter 2013 Financial Results
2013-07-12,Biotech Stock Mailbag: GTx, Vanda, Pharmacyclics
2013-07-11,October 19th Options Now Available For GTx
2013-07-10,The GTx Cancer Muscle-Wasting Drug Studies Will Fail. Here's Why
2013-06-28,GTx Presents On Enobosarm For The Prevention And Treatment Of Muscle Wasting In Cancer Patients At The 2013 MASCC/ISOO International Symposium On Supportive Care In Cancer
2013-06-24,GTx Announces Symposium And Presentation Of Scientific Poster Presentations On Enobosarm At The 2013 MASCC/ISOO International Symposium On Supportive Care In Cancer
2013-06-07,Biotech Stock Mailbag: 2013 Clinical Trials Calendar
2013-05-23,Commit To Buy GTx At $4, Earn 69% Annualized
2013-04-18,5 Health Care Stocks Under $10 Ready to Rip Higher
2013-03-19,GTx-758 Poster Presentation Of Phase II Trial Data In Advanced Prostate Cancer Selected As One Of The Best Posters At The 28th Annual European Association Of Urology Congress
2013-03-14,Enobosarm Phase 2 Trial For Muscle Wasting And Physical Function In Patients With Cancer Published In The Lancet Oncology
2013-02-27,GTx Announces Webcast Of Corporate Presentation At Cowen And Company 33rd Annual Health Care Conference
2013-02-21,GTx Provides Corporate Update And Reports 2012 Financial Results
2013-02-19,GTx Announces Webcast Of Corporate Presentation At 2013 Citi Global Healthcare Conference
2013-02-14,GTx To Present Preclinical Data On A New Therapeutic Target In Prostate Cancer
2013-02-13,Novel Findings From Clinical Studies Examining The Effects Of Capesaris&#174; (GTx-758) For The Treatment Of Advanced Prostate Cancer To Be Presented At 2013 American Society Of Clinical Oncology Genitourinary Cancer Symposium
2013-02-12,GTx Announces Webcast For Capesaris&#174;(GTx-758) Analyst Day
2013-02-07,GTx, Inc. To Host Fourth Quarter And Full Year 2012 Financial Results Conference Call And Webcast
2013-02-05,GTx Announces Webcast Of Corporate Presentation At Bio CEO &amp; Investor Conference
2013-01-08,GTx Announces FDA&#8217;s Grant Of Fast Track Designation To Enobosarm For The Prevention And Treatment Of Muscle Wasting In Patients With Non-Small Cell Lung Cancer
2012-12-17,GTx Attains Enrollment Goal For Its Enobosarm POWER 1 And POWER 2 Phase III Clinical Studies
2012-12-11,4 Stocks Soaring on Unusual Volume
2012-11-08,GTx Announces Webcast Of Corporate Presentation At Jefferies 2012 Global Healthcare Conference
2012-11-08,GTx Provides Corporate Update And Reports Third Quarter 2012 Financial Results
2012-11-06,GTx Announces Webcast Of Corporate Presentation At Lazard Capital Markets 9th Annual Healthcare Conference
2012-10-29,GTx's Phase III Clinical Development Of Enobosarm (GTx-024) For Muscle Wasting In Lung Cancer Patients On Course Following Planned Safety Review
2012-10-25,GTx, Inc. To Host Third Quarter 2012 Financial Results Conference Call And Webcast
2012-10-08,GTx To Present Scientific Poster Presentations On Enobosarm To Prevent And Treat Muscle Wasting In Cancer Patients
2012-10-01,GTx Announces Sale Of Fareston&#174;
2012-09-19,GTx Announces Presentation On The Ability Of Capesaris&#174; To Reduce Free Testosterone And Suppress PSA In Men With Castration Resistant Prostate Cancer
2012-09-17,GTx Announces Symposium And Presentation Of Data On Muscle Wasting In Non-Small Cell Lung Cancer Patients
2012-08-28,GTx Announces Webcast Of Corporate Presentation At NewsMakers In The Biotech Industry Conference
2012-08-27,GTx Announces Webcast Of Corporate Presentation At Stifel Nicolaus 2012 Healthcare Conference
2012-08-14,5 Biotech Stocks Under $10 Blasting Higher
2012-08-08,GTx's CEO Discusses Q2 2012 Results - Earnings Call Transcript
2012-08-08,GTx Provides Corporate Update And Reports Second Quarter 2012 Financial Results
2012-08-06,GTx Announces Webcast Of Corporate Presentation At Wedbush 2012 Life Sciences: Management Access Conference
2012-07-26,GTx, Inc. To Host Second Quarter 2012 Financial Results Conference Call And Webcast
2012-06-26,GTx Announces Presentations On The Effect Of Enobosarm On Improving Physical Function In Cancer Patients
2012-06-25,GTx Announces Presentation On Enobosarm&#8217;s Improvement In Physical Function In Cancer Patients With Both Low And Normal Testosterone Levels
2012-06-22,GTx Announces Panel Presentation On Muscle Wasting In Non-Small Cell Lung Cancer Patients
2012-06-13,GTx Announces Poster Presentation On The Prevalence And Impact Of Hypogonadism In Cancer Patients With Muscle Wasting From Its Phase IIb Enobosarm Clinical Trial At The Endocrine Society&#8217;s 2012 Annual Meeting
2012-05-29,GTx Announces Webcast Of Corporate Presentation At Jefferies 2012 Global Healthcare Conference
2012-05-08,7 Stocks Soaring in a Weak Market
2012-05-08,GTx Announces Removal Of Full Clinical Hold By FDA For Capesaris&#174; In Advanced Prostate Cancer
2012-04-25,GTx, Inc. To Host First Quarter 2012 Financial Results Conference Call And Webcast
2012-04-04,GTx Submits Clinical Hold Complete Response Letter To FDA For Its Planned Phase II Clinical Study Of Capesaris&#174; For Secondary Hormonal Therapy Of Advanced Prostate Cancer
2012-03-15,5 Stocks Insiders Love Right Now
2012-03-02,GTx Announces Webcast Of Corporate Presentation At The Cowen And Co. Annual Health Care Conference
2012-02-24,GTx Announces Webcast Of Corporate Presentation At The Citi 2012 Global Health Care Conference
2012-02-21,GTx Stock Gaps Down On Today's Open (GTXI)
2012-02-21,GTx Provides Corporate Update And Reports 2011 Financial Results
2012-02-21,GTx Announces Clinical Hold On Clinical Trials Evaluating Capesaris&#174; For First And Second Line Treatments Of Advanced Prostate Cancer
2012-02-13,GTx, Inc. To Host Fourth Quarter And Full Year 2011 Financial Results Conference Call And Webcast
2011-11-10,GTx Announces Webcast Of Corporate Presentation At The Lazard Capital Markets Annual Healthcare Conference
2011-11-04,GTx, Inc. Provides Corporate Update And Reports Third Quarter 2011 Financial Results
2011-10-21,GTx, Inc. To Host Third Quarter 2011 Financial Results Conference Call And Webcast
2011-08-31,GTx Announces Panel Discussion At Citi&#8217;s 6th Annual Biotech Day
2011-08-11,GTx Announces Webcast Of Corporate Presentation At The 2011 Wedbush Life Sciences Conference
2011-08-09,GTx, Inc. Provides Corporate Update And Reports Second Quarter 2011 Financial Results
2011-07-28,GTx, Inc. To Host Second Quarter 2011 Financial Results Conference Call And Webcast
2011-07-01,5 Stocks With Big Insider Buying
2011-06-30,GTx Announces Upcoming Presentations Of Effects Of Ostarine&#8482; In Non-Small Cell Lung Cancer Patients At World Conference On Lung Cancer
2011-06-29,Insiders Trading KIOR, NWN, GTXI
2011-06-28,10 Cheap Biotech Stocks That Could Soar
2011-06-23,GTx Announces Pricing Of Public Offering Of Common Stock
2011-06-22,GTx Announces Proposed Public Offering Of Common Stock
2011-06-20,GTx Initiates Phase IIb Clinical Trial Evaluating&#160;Oral&#160;Capesaris&#8482;&#160;Tablets Versus Lupron&#160;Depot&#174;&#160;for First Line Treatment Of Advanced Prostate Cancer
2011-06-13,GTx Set To Join Russell 3000 Index
2011-06-06,GTx Announces Agreement With FDA On Phase III Clinical Development Plan Evaluating Ostarine&#8482; (GTx-024) For The Prevention And Treatment Of Muscle Wasting In Patients With Non-Small Cell Lung Cancer
2011-05-18,GTx Announces ASCO Presentations Highlighting Effects Of Ostarine&#8482; On Physical Function And Survival In Patients With Non-Small Cell Lung Cancer
2011-05-17,GTx Presents Preclinical Study Results Demonstrating That Capesaris&#8482; (GTx-758) Chronic Treatment Does Not Cause Gynecomastia In Male Primates
2011-05-11,GTx Inc. Stock Downgraded (GTXI)
2011-05-09,GTx Inc. Stock Upgraded (GTXI)
2011-05-09,GTx Provides Corporate Update And Reports First Quarter 2011 Financial Results
2011-05-02,GTx, Inc. To Host First Quarter 2011 Financial Results Conference Call And Webcast
2011-03-02,GTx And Ipsen Terminate Their Toremifene Collaboration
2011-03-01,GTx Announces Webcast Of Corporate Presentation At The Cowen And Company Annual Health Care Conference
2011-02-24,GTx Provides Corporate Update And Reports 2010 Financial Results
2011-02-23,GTx Announces Webcast Of Corporate Presentation At The Citi 2011 Global Health Care Conference
2011-02-17,GTx Announces Presentation At The ASCO Genitourinary Cancers Symposium Of Additional Study Results From The Phase III Clinical Trial Evaluating Toremifene 80 Mg For The Reduction Of Fractures In Men With Prostate Cancer On ADT
2011-02-15,GTx, Inc. To Host Fourth Quarter And Year End 2010 Financial Results Conference Call And Webcast
2011-01-04,GTx Announces Webcast Of Corporate Presentation At The JP Morgan Healthcare Conference
2010-12-13,GTx Presents Results Of The Capesaris&#8482; (GTx-758) Phase II Proof Of Concept Pharmacokinetic-Pharmacodynamic Clinical Trial
2010-11-15,GTx Presents Preclinical Studies Of GTx-758, A Selective Estrogen Receptor Alpha Agonist For First Line Treatment Of Advanced Prostate Cancer, And GTx-230, An Orally Available Tubulin Antagonist For Cancer Refractory To Taxane And Vinca Alkaloid Therapy
2010-11-11,GTx Announces Corporate Presentation At The Lazard Capital Markets Annual Healthcare Conference
2010-11-09,GTx, Inc. Reports Third Quarter 2010 Corporate Results
2010-11-08,GTx Appoints Dr. Barry Furr To The Board Of Directors
2010-11-03,GTx Awarded $1.2 Million In Grants For Qualifying Therapeutic Discovery Projects
2010-11-02,GTx, Inc. Announces Third Quarter 2010 Financial Results Conference Call And Webcast
2010-10-27,GTx Announces Pricing Of Public Offering Of Common Stock
2010-10-26,GTx Announces Proposed Public Offering Of Common Stock
2017-03-15,GTx Provides Corporate Update And Reports Fourth Quarter And Year-End 2016 Financial Results
2017-03-07,GTx, Inc. To Report Fourth Quarter And Full Year 2016 Financial Results On March 15, 2017
2016-12-08,GTx Reports Results From Ongoing Enobosarm Phase 2 Clinical Trial In ER+/AR+ Breast Cancer
2016-12-05,GTx, Inc. Announces 1-for-10 Reverse Stock Split
2016-11-28,Enobosarm Meets Pre-Specified Primary Efficacy Endpoint In Ongoing Phase 2 Clinical Trial In ER+/AR+ Breast Cancer
2016-11-23,GTx Announces Webcast Of Corporate Presentation At The 28th Annual Piper Jaffray Healthcare Conference
2016-11-16,GTx Achieves Second Stage 1 Milestone In Phase 2 Clinical Trial Of Enobosarm In ER+/AR+ Breast Cancer
2016-11-11,GTx Announces Webcast Of Corporate Presentation At The Stifel 2016 Healthcare Conference
2016-11-03,GTx Provides Corporate Update And Reports Third Quarter 2016 Financial Results
2016-10-12,GTx Announces $14.0 Million Registered Direct Common Stock Offering
2016-09-08,GTx Achieves Stage 1 Milestone In Phase 2 Clinical Trial Of Enobosarm In ER+/AR+ Breast Cancer
2016-09-02,GTx Announces Webcast Of Corporate Presentation At Baird's 2016 Healthcare Conference
2016-09-01,GTx Appoints Dr. Garry Neil To Board Of Directors
2016-08-09,GTx Provides Corporate Update And Reports Second Quarter 2016 Financial Results
2016-07-05,XBiotech Cancer Drug Survival Claim Falls Apart Under Scrutiny
2016-06-02,GTx Announces Webcast Of Corporate Presentation At Jefferies 2016 Global Healthcare Conference
2016-05-16,GTx Announces Webcast Of Corporate Presentation At The UBS Global Healthcare Conference 2016
2016-05-10,GTx Provides Corporate Update And Reports First Quarter 2016 Financial Results
2016-05-09,GTx Announces Presentation Of Preclinical Data Demonstrating The Ability Of SARDs To Degrade And Inhibit The Androgen Receptor At The American Urological Association Annual Meeting
2016-04-27,GTx, Inc. To Report First Quarter 2016 Financial Results On May 10, 2016
2016-03-03,GTx Provides Corporate Update And Reports Fourth Quarter And Year-End 2015 Financial Results
2016-02-24,GTx Announces Presentation Of Preclinical Data Demonstrating The Effect Of GTx SARMs On Pelvic Floor Muscle Loss At The Society Of Urodynamics, Female Pelvic Medicine And Urogenital Reconstruction (SUFU) Meeting
2016-02-18,GTx, Inc. To Host Fourth Quarter And Full Year 2015 Financial Results Conference Call And Webcast
2016-01-13,GTx Announces Initiation Of Phase 2 Clinical Trial Of Enobosarm In Stress Urinary Incontinence
2015-10-29,GTx Provides Corporate Update And Reports Third Quarter 2015 Financial Results
2015-10-15,GTx, Inc. To Host Third Quarter 2015 Financial Results Conference Call And Webcast
2015-10-13,GTx Receives FDA Clearance To Initiate Clinical Trial In Stress Urinary Incontinence
2015-10-06,GTx Announces Enrollment Of First Patient In Phase 2 Clinical Trial Of Enobosarm In Triple Negative Breast Cancer
2015-09-29,GTx Announces Enrollment Of First Patient In Phase 2 Clinical Trial Of Enobosarm In ER+/AR+ Breast Cancer
2015-08-06,GTx Provides Corporate Update And Reports Second Quarter 2015 Financial Results
2015-07-23,GTx, Inc. To Host Second Quarter 2015 Financial Results Conference Call And Webcast
2015-07-08,GTx Appoints Diane Young, M.D. As Vice President, Chief Medical Officer
2015-06-02,GTx Regains Compliance With NASDAQ Bid Price Requirement
2015-05-26,GTx Announces Webcast Of Corporate Presentation At Jefferies 2015 Global Healthcare Conference
2015-05-12,GTx Announces Webcast Of Corporate Presentation At The UBS Global Healthcare Conference 2015
2015-05-08,GTx Provides Corporate Update And Reports First Quarter 2015 Financial Results
2015-04-30,3 Stocks Under $10 to Trade for Big Breakouts
2015-04-23,GTx And The University Of Tennessee Research Foundation Enter Into Exclusive License Agreement To Develop UTRF's SARD Drug Technology
2015-04-02,GTx Provides Corporate Update Regarding NASDAQ Stock Listing
2015-03-04,GTx Provides Corporate Update And Reports Fourth Quarter And Year-End 2014 Financial Results
2015-02-19,GTx, Inc. To Host Fourth Quarter And Full Year 2014 Financial Results Conference Call And Webcast
2015-02-17,GTx Appoints Robert J. Wills, Ph.D. To Board Of Directors
2014-12-08,GTx To Present Results On Enobosarm 9mg In Women With Metastatic Breast Cancer At 2014 San Antonio Breast Cancer Symposium
2014-11-17,GTx Announces Closing Of $43.4 Private Placement
2014-11-12,GTx Announces Webcast Of Corporate Presentation At The Stifel 2014 Healthcare Conference
2014-11-10,GTx Provides Corporate Update And Reports Third Quarter 2014 Financial Results
2014-11-10,GTx Announces $43.4 Million Private Placement
2014-11-03,GTx, Inc. To Host Third Quarter 2014 Financial Results Conference Call And Webcast
2014-08-07,GTx Announces Webcast Of Corporate Presentation At The 2014 Wedbush Pacgrow Life Sciences Management Access Conference
2014-08-05,GTx Provides Corporate Update And Reports Second Quarter 2014 Financial Results
2014-07-22,GTx, Inc. To Report Second Quarter 2014 Financial Results On August 5, 2014
2014-07-02,4 Biotech Stocks Under $10 to Watch for Breakout Trades
2014-06-02,GTx Reports Positive Clinical Data From Open Label Phase 2 Study Of Enobosarm In Patients With Androgen And Estrogen Receptor Positive Metastatic Breast Cancer
2014-05-22,GTx Announces Webcast Of Corporate Presentation At Jefferies 2014 Global Healthcare Conference
2014-05-19,GTx To Present Clinical Data On Enobosarm In Breast Cancer And NSCLC At ASCO 2014 Annual Meeting
2014-05-08,GTx Provides Corporate Update And Reports First Quarter 2014 Financial Results
2014-04-24,GTx, Inc. To Report First Quarter 2014 Financial Results On May 8, 2014
2014-04-04,GTx Announces Departure Of CEO
2014-03-06,GTx, Inc. Announces Closing Of Private Placement
2014-03-05,GTx Announces Webcast Of Corporate Presentation At 26TH Annual ROTH Conference
2014-03-04,GTx Provides Corporate Update And Reports 2013 Financial Results
2014-03-04,GTx, Inc. Announces Pricing Of Private Placement
2014-02-26,GTx Announces Webcast Of Corporate Presentation At Cowen And Company 34th Annual Health Care Conference
2014-02-18,GTx, Inc. To Host Fourth Quarter And Full Year 2013 Financial Results Conference Call And Webcast
2014-02-04,First Week of March 22nd Options Trading For GTXI
2014-02-04,GTx Announces Webcast Of Corporate Presentation At Bio CEO &amp; Investor Conference
2014-01-29,Preliminary Findings From The Phase 2 Clinical Trial Of GTx-758 In Men With Castration Resistant Prostate Cancer To Be Presented At ASCO Genitourinary Cancer Symposium
2013-12-19,5 Stocks Under $10 Set to Soar
2013-12-12,GTx Presents On Enobosarm As Targeted Therapy For The Treatment Of Androgen Receptor-Positive Breast Cancer At The San Antonio Breast Cancer Symposium
2013-11-12,GTx Provides Corporate Update And Reports Third Quarter 2013 Financial Results
2013-10-29,GTx, Inc. To Host Third Quarter 2013 Financial Results Conference Call And Webcast
2013-10-24,GTx Presents Results From Enobosarm POWER Trials For The Prevention And Treatment Of Muscle Wasting In Patients With Non-Small Cell Lung Cancer At 15th World Conference On Lung Cancer
2013-09-24,GTx Announces Late Breaker Presentation On Results From The Two Phase 3 POWER Trials Of Enobosarm, A Selective Androgen Receptor Modulator (SARM), For The Prevention And Treatment Of Muscle Wasting In NSCLC Patients During 2013 European Cancer Congress
2013-09-16,5 Stocks Ready for Breakouts
2013-09-11,6 Under-$10 Stocks Moving Higher
2013-09-06,GTx Announces Webcast Of Corporate Presentation At Stifel Nicolaus 2013 Healthcare Conference
2013-08-29,GTx, Inc. Sued By Investor
2013-08-27,Short Interest In GTx Inc Increases 32%
2013-08-23,Top Insider Trades: GLP ACW GTXI AHH
2013-08-23,The 5 Dumbest Things on Wall Street This Week: Aug. 23
2013-08-23,5 Dumbest Things on Wall Street
2013-08-19,Shareholder Rights Law Firm Johnson &amp; Weaver, LLP Announces Investigation Of GTx Inc.
2013-08-19,GTXI SHAREHOLDER ALERT: The Law Firm Of Wohl &amp; Fruchter LLP Announces Investigation Of GTX Inc.
2013-08-19,GTx: Survival Spin Job Follows Enobosarm Study Flop
2013-08-19,GTx Reports Results For Enobosarm POWER Trials For The Prevention And Treatment Of Muscle Wasting In Patients With Non-Small Cell Lung Cancer
2013-08-12,Short Interest Moves 47.3% Higher For GTXI
2013-08-04,MannKind, Vical, GTx: Investors Predict Pivotal Clinical Trial Results
2013-08-02,GTx Inc Is Now Oversold (GTXI)
2013-07-19,GTx Provides Corporate Update And Second Quarter 2013 Financial Results
2013-07-12,Biotech Stock Mailbag: GTx, Vanda, Pharmacyclics
2013-07-11,October 19th Options Now Available For GTx
2013-07-10,The GTx Cancer Muscle-Wasting Drug Studies Will Fail. Here's Why
2013-06-28,GTx Presents On Enobosarm For The Prevention And Treatment Of Muscle Wasting In Cancer Patients At The 2013 MASCC/ISOO International Symposium On Supportive Care In Cancer
2013-06-24,GTx Announces Symposium And Presentation Of Scientific Poster Presentations On Enobosarm At The 2013 MASCC/ISOO International Symposium On Supportive Care In Cancer
2013-06-07,Biotech Stock Mailbag: 2013 Clinical Trials Calendar
2013-05-23,Commit To Buy GTx At $4, Earn 69% Annualized
2013-04-18,5 Health Care Stocks Under $10 Ready to Rip Higher
2013-03-19,GTx-758 Poster Presentation Of Phase II Trial Data In Advanced Prostate Cancer Selected As One Of The Best Posters At The 28th Annual European Association Of Urology Congress
2013-03-14,Enobosarm Phase 2 Trial For Muscle Wasting And Physical Function In Patients With Cancer Published In The Lancet Oncology
2013-02-27,GTx Announces Webcast Of Corporate Presentation At Cowen And Company 33rd Annual Health Care Conference
2013-02-21,GTx Provides Corporate Update And Reports 2012 Financial Results
2013-02-19,GTx Announces Webcast Of Corporate Presentation At 2013 Citi Global Healthcare Conference
2013-02-14,GTx To Present Preclinical Data On A New Therapeutic Target In Prostate Cancer
2013-02-13,Novel Findings From Clinical Studies Examining The Effects Of Capesaris&#174; (GTx-758) For The Treatment Of Advanced Prostate Cancer To Be Presented At 2013 American Society Of Clinical Oncology Genitourinary Cancer Symposium
2013-02-12,GTx Announces Webcast For Capesaris&#174;(GTx-758) Analyst Day
2013-02-07,GTx, Inc. To Host Fourth Quarter And Full Year 2012 Financial Results Conference Call And Webcast
2013-02-05,GTx Announces Webcast Of Corporate Presentation At Bio CEO &amp; Investor Conference
2013-01-08,GTx Announces FDA&#8217;s Grant Of Fast Track Designation To Enobosarm For The Prevention And Treatment Of Muscle Wasting In Patients With Non-Small Cell Lung Cancer
2012-12-17,GTx Attains Enrollment Goal For Its Enobosarm POWER 1 And POWER 2 Phase III Clinical Studies
2012-12-11,4 Stocks Soaring on Unusual Volume
2012-11-08,GTx Announces Webcast Of Corporate Presentation At Jefferies 2012 Global Healthcare Conference
2012-11-08,GTx Provides Corporate Update And Reports Third Quarter 2012 Financial Results
2012-11-06,GTx Announces Webcast Of Corporate Presentation At Lazard Capital Markets 9th Annual Healthcare Conference
2012-10-29,GTx's Phase III Clinical Development Of Enobosarm (GTx-024) For Muscle Wasting In Lung Cancer Patients On Course Following Planned Safety Review
2012-10-25,GTx, Inc. To Host Third Quarter 2012 Financial Results Conference Call And Webcast
2012-10-08,GTx To Present Scientific Poster Presentations On Enobosarm To Prevent And Treat Muscle Wasting In Cancer Patients
2012-10-01,GTx Announces Sale Of Fareston&#174;
2012-09-19,GTx Announces Presentation On The Ability Of Capesaris&#174; To Reduce Free Testosterone And Suppress PSA In Men With Castration Resistant Prostate Cancer
2012-09-17,GTx Announces Symposium And Presentation Of Data On Muscle Wasting In Non-Small Cell Lung Cancer Patients
2012-08-28,GTx Announces Webcast Of Corporate Presentation At NewsMakers In The Biotech Industry Conference
2012-08-27,GTx Announces Webcast Of Corporate Presentation At Stifel Nicolaus 2012 Healthcare Conference
2012-08-14,5 Biotech Stocks Under $10 Blasting Higher
2012-08-08,GTx's CEO Discusses Q2 2012 Results - Earnings Call Transcript
2012-08-08,GTx Provides Corporate Update And Reports Second Quarter 2012 Financial Results
2012-08-06,GTx Announces Webcast Of Corporate Presentation At Wedbush 2012 Life Sciences: Management Access Conference
2012-07-26,GTx, Inc. To Host Second Quarter 2012 Financial Results Conference Call And Webcast
2012-06-26,GTx Announces Presentations On The Effect Of Enobosarm On Improving Physical Function In Cancer Patients
2012-06-25,GTx Announces Presentation On Enobosarm&#8217;s Improvement In Physical Function In Cancer Patients With Both Low And Normal Testosterone Levels
2012-06-22,GTx Announces Panel Presentation On Muscle Wasting In Non-Small Cell Lung Cancer Patients
2012-06-13,GTx Announces Poster Presentation On The Prevalence And Impact Of Hypogonadism In Cancer Patients With Muscle Wasting From Its Phase IIb Enobosarm Clinical Trial At The Endocrine Society&#8217;s 2012 Annual Meeting
2012-05-29,GTx Announces Webcast Of Corporate Presentation At Jefferies 2012 Global Healthcare Conference
2012-05-08,7 Stocks Soaring in a Weak Market
2012-05-08,GTx Announces Removal Of Full Clinical Hold By FDA For Capesaris&#174; In Advanced Prostate Cancer
2012-04-25,GTx, Inc. To Host First Quarter 2012 Financial Results Conference Call And Webcast
2012-04-04,GTx Submits Clinical Hold Complete Response Letter To FDA For Its Planned Phase II Clinical Study Of Capesaris&#174; For Secondary Hormonal Therapy Of Advanced Prostate Cancer
2012-03-15,5 Stocks Insiders Love Right Now
2012-03-02,GTx Announces Webcast Of Corporate Presentation At The Cowen And Co. Annual Health Care Conference
2012-02-24,GTx Announces Webcast Of Corporate Presentation At The Citi 2012 Global Health Care Conference
2012-02-21,GTx Stock Gaps Down On Today's Open (GTXI)
2012-02-21,GTx Provides Corporate Update And Reports 2011 Financial Results
2012-02-21,GTx Announces Clinical Hold On Clinical Trials Evaluating Capesaris&#174; For First And Second Line Treatments Of Advanced Prostate Cancer
2012-02-13,GTx, Inc. To Host Fourth Quarter And Full Year 2011 Financial Results Conference Call And Webcast
2011-11-10,GTx Announces Webcast Of Corporate Presentation At The Lazard Capital Markets Annual Healthcare Conference
2011-11-04,GTx, Inc. Provides Corporate Update And Reports Third Quarter 2011 Financial Results
2011-10-21,GTx, Inc. To Host Third Quarter 2011 Financial Results Conference Call And Webcast
2011-08-31,GTx Announces Panel Discussion At Citi&#8217;s 6th Annual Biotech Day
2011-08-11,GTx Announces Webcast Of Corporate Presentation At The 2011 Wedbush Life Sciences Conference
2011-08-09,GTx, Inc. Provides Corporate Update And Reports Second Quarter 2011 Financial Results
2011-07-28,GTx, Inc. To Host Second Quarter 2011 Financial Results Conference Call And Webcast
2011-07-01,5 Stocks With Big Insider Buying
2011-06-30,GTx Announces Upcoming Presentations Of Effects Of Ostarine&#8482; In Non-Small Cell Lung Cancer Patients At World Conference On Lung Cancer
2011-06-29,Insiders Trading KIOR, NWN, GTXI
2011-06-28,10 Cheap Biotech Stocks That Could Soar
2011-06-23,GTx Announces Pricing Of Public Offering Of Common Stock
2011-06-22,GTx Announces Proposed Public Offering Of Common Stock
2011-06-20,GTx Initiates Phase IIb Clinical Trial Evaluating&#160;Oral&#160;Capesaris&#8482;&#160;Tablets Versus Lupron&#160;Depot&#174;&#160;for First Line Treatment Of Advanced Prostate Cancer
2011-06-13,GTx Set To Join Russell 3000 Index
2011-06-06,GTx Announces Agreement With FDA On Phase III Clinical Development Plan Evaluating Ostarine&#8482; (GTx-024) For The Prevention And Treatment Of Muscle Wasting In Patients With Non-Small Cell Lung Cancer
2011-05-18,GTx Announces ASCO Presentations Highlighting Effects Of Ostarine&#8482; On Physical Function And Survival In Patients With Non-Small Cell Lung Cancer
2011-05-17,GTx Presents Preclinical Study Results Demonstrating That Capesaris&#8482; (GTx-758) Chronic Treatment Does Not Cause Gynecomastia In Male Primates
2011-05-11,GTx Inc. Stock Downgraded (GTXI)
2011-05-09,GTx Inc. Stock Upgraded (GTXI)
2011-05-09,GTx Provides Corporate Update And Reports First Quarter 2011 Financial Results
2011-05-02,GTx, Inc. To Host First Quarter 2011 Financial Results Conference Call And Webcast
2011-03-02,GTx And Ipsen Terminate Their Toremifene Collaboration
2011-03-01,GTx Announces Webcast Of Corporate Presentation At The Cowen And Company Annual Health Care Conference
2011-02-24,GTx Provides Corporate Update And Reports 2010 Financial Results
2011-02-23,GTx Announces Webcast Of Corporate Presentation At The Citi 2011 Global Health Care Conference
2011-02-17,GTx Announces Presentation At The ASCO Genitourinary Cancers Symposium Of Additional Study Results From The Phase III Clinical Trial Evaluating Toremifene 80 Mg For The Reduction Of Fractures In Men With Prostate Cancer On ADT
2011-02-15,GTx, Inc. To Host Fourth Quarter And Year End 2010 Financial Results Conference Call And Webcast
2011-01-04,GTx Announces Webcast Of Corporate Presentation At The JP Morgan Healthcare Conference
2010-12-13,GTx Presents Results Of The Capesaris&#8482; (GTx-758) Phase II Proof Of Concept Pharmacokinetic-Pharmacodynamic Clinical Trial
2010-11-15,GTx Presents Preclinical Studies Of GTx-758, A Selective Estrogen Receptor Alpha Agonist For First Line Treatment Of Advanced Prostate Cancer, And GTx-230, An Orally Available Tubulin Antagonist For Cancer Refractory To Taxane And Vinca Alkaloid Therapy
2010-11-11,GTx Announces Corporate Presentation At The Lazard Capital Markets Annual Healthcare Conference
2010-11-09,GTx, Inc. Reports Third Quarter 2010 Corporate Results
2010-11-08,GTx Appoints Dr. Barry Furr To The Board Of Directors
2010-11-03,GTx Awarded $1.2 Million In Grants For Qualifying Therapeutic Discovery Projects
2010-11-02,GTx, Inc. Announces Third Quarter 2010 Financial Results Conference Call And Webcast
2010-10-27,GTx Announces Pricing Of Public Offering Of Common Stock
2010-10-26,GTx Announces Proposed Public Offering Of Common Stock
